Golden
Brace Pharma Capital

Brace Pharma Capital

Brace Pharma Capital is the strategic investment subsidiary of EMS S/A and focus their investments on therapies for diseases with a high degree of unmet medical need and insufficient treatment options.

Brace Pharma Capital is the strategic investment subsidiary of EMS S/A, a Brazilian pharmaceutical company. They invest in therapies for diseases with a high degree of unmet medical need and insufficient treatment options. Brace Pharma Capital invest 80% of their portfolio in clinical phase projects, and the remaining 20% in pre-clinical projects. 



Part of their investment criteria, Brace Pharma Capital looks for therapies with what they deem a high probability of technical and regulatory success with defined, FDA validated, clinical efficacy endpoints. And they look for clinical stage projects to go to market in three to five years, and pre-clinical to go to market in five to seven years with the potential of over $200 million in revenue.

Investment

Brace Pharma Capital has invested in Avidity Biosciences, ReViral, Antiva Biosciences, Prevision BioSciences, AVROBIO, Antiva Biosciences, MiRagen, F2G, Zymeworks and Navitor Pharmaceuticals.



They have exited their investments in Precision BioSciences, Zymeworks, Avrobio, UNUM Therapeutics, and MiRagen.

Timeline

Funded Companies

4 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

Precision BioSciences is a biotechnology developing a gene editing platform for the creation of cell therapies, gene therapies, and agricultural products.

Developing gene therapies to potentially cure rare diseases.

Avidity Biosciences is a La Jolla-based company.

Antiva Biosciences is a Menlo Park, California-based company.

People

Name
Role
LinkedIn

Alan Cohen, M.D., FAAP, FCCP, FAAAAI, FACAAI

Medical Advisor



Daniel E. Salazar, Ph.D

Vice President of Clinical & Regulatory



Lina Arslanian

Executive Assistant & Office Manager



Pedro Bordeaux, M.S.

Associate



Samuel Broder, M.D.

Medical Advisor



Todd Brady

Director of Finance & Investments



Vinzenz Ploerer

President and CEO



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References